Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset.
about
Immunomodulatory treatment of myelodysplastic syndromes: antithymocyte globulin, cyclosporine, and alemtuzumabDeregulation of innate immune and inflammatory signaling in myelodysplastic syndromesAbnormalities of the alphabeta T-cell receptor repertoire in advanced myelodysplastic syndrome.T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS.The epigenetic drug 5-azacytidine interferes with cholesterol and lipid metabolismCurrent therapy of myelodysplastic syndromesDepletion of cytotoxic T-cells does not protect NUP98-HOXD13 mice from myelodysplastic syndrome but reveals a modest tumor immunosurveillance effect.Th22 cells as well as Th17 cells expand differentially in patients with early-stage and late-stage myelodysplastic syndrome.Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy.CD4+ and CD8+ T-cell skewness in classic Kaposi sarcoma.A case report: Concurrent chronic myelomonocytic leukemia and T-cell large granular lymphocytic leukemia-type clonal proliferation as detected by multiparametric flow cytometry.Immune alterations in untreated and treated myelodysplastic syndrome.Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy.Are T-cell dysfunctions the other side of the moon in the pathogenesis of myelodysplastic syndromes?The B7 homologues and their receptors in hematologic malignancies.Myelodysplastic syndromes: toward a risk-adapted treatment approach.The burden of autoimmunity in myelodysplastic syndromes.Polymorphisms of IL-10 affect the severity and prognosis of myelodysplastic syndrome.Derangement of the T-cell repertoire in patients with B-cell non-Hodgkin's lymphoma.Patients with early-stage myelodysplastic syndromes show increased frequency of CD4+CD25+CD127(low) regulatory T cells.Hypomegakaryocytic thrombocytopenia and increased number of PNH-phenotype cells - an emerging subgroup of myelodysplastic syndrome showing frequent response to immunosuppression.Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5q.DNA Methyltransferase Inhibition Promotes Th1 Polarization in Human CD4+CD25high FOXP3+ Regulatory T Cells but Does Not Affect Their Suppressive Capacity.Immunemodulatory Effects of 5-Azacitidin Through Expansion of Functional Regulatory T Cells on Paraneoplastic Inflammation Associated With Myelodysplastic Syndromes: A Case Report.
P2860
Q26864200-5B47F41C-775A-467E-BD7E-EB15FD25973CQ27015288-39827EB7-228A-45B0-98EC-33136A3695E0Q33679140-9A2FFB14-023F-4EF7-83FD-E064AF5E01B7Q33702157-4695F46E-0C07-43CB-82F5-E76FCCEED24BQ33846421-43147F71-B1F2-4164-A20F-680EB3C565EDQ34013796-05205B55-5259-4F18-845B-C0C10306A99BQ34273750-D1153913-E0B8-4B28-ADA3-187D429F014EQ34510880-F3C87CB4-497C-4682-A56F-346BAD846343Q35613049-F9AF015C-8B8C-4441-9FA5-7B12B254A72DQ36088171-8DEA7BF3-BBA1-4DD0-B60D-01C38EF3C194Q37845291-EA49D47B-6FB5-48C2-8693-65F20A2BD3F6Q37854701-0EC3F653-56C1-4517-9EF5-51C5A90361C0Q37864686-7D42B820-DD4B-4474-84C5-4CA4AA13831CQ37980495-7ADD7FFC-B57D-4E98-AE0D-1AB699F8A281Q37988965-EC075621-9917-407A-94B9-A100CE036A1CQ38149315-564968B3-4DA7-46BB-B2CF-97900C3871C8Q39267232-5E68C35C-B9C5-46A1-8C39-6562F6B93DCDQ42144212-E0659AA4-C1F1-418E-BC88-45DDFB4B9487Q43683700-C860FEE8-26D0-4957-A3F0-8ED8B1329DA4Q47267238-37430C37-EEFE-447C-9BF6-7CCE53FA9CCBQ48100563-9B65AC38-E871-47F0-A5F2-446D4B678044Q51579894-D9786F04-D8A7-4C67-84EE-822DD5ED1F8EQ55078696-BCAC763E-096F-4811-AFA9-06E9545CFA45Q55257366-F607B066-5CE8-45B8-9DEA-0D97D8296726
P2860
Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Patients with myelodysplastic ...... goclonal in the CD8(+) subset.
@en
Patients with myelodysplastic ...... goclonal in the CD8(+) subset.
@nl
type
label
Patients with myelodysplastic ...... goclonal in the CD8(+) subset.
@en
Patients with myelodysplastic ...... goclonal in the CD8(+) subset.
@nl
prefLabel
Patients with myelodysplastic ...... goclonal in the CD8(+) subset.
@en
Patients with myelodysplastic ...... goclonal in the CD8(+) subset.
@nl
P2093
P1476
Patients with myelodysplastic ...... goclonal in the CD8(+) subset.
@en
P2093
Antonio Galleu
Claudio Fozza
Maria Pina Simula
Maurizio Longinotti
Patrizia Virdis
Salvatore Contini
Silvana Bonfigli
P304
P356
10.1016/J.EXPHEM.2009.04.009
P577
2009-05-04T00:00:00Z